These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


323 related items for PubMed ID: 21034829

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protection from persistent infection with a bovine viral diarrhea virus (BVDV) type 1b strain by a modified-live vaccine containing BVDV types 1a and 2, infectious bovine rhinotracheitis virus, parainfluenza 3 virus and bovine respiratory syncytial virus.
    Xue W, Mattick D, Smith L.
    Vaccine; 2011 Jun 24; 29(29-30):4657-62. PubMed ID: 21596076
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunogenicity of an inactivated Chinese bovine viral diarrhea virus 1a (BVDV 1a) vaccine cross protects from BVDV 1b infection in young calves.
    Wang W, Shi X, Wu Y, Li X, Ji Y, Meng Q, Zhang S, Wu H.
    Vet Immunol Immunopathol; 2014 Aug 15; 160(3-4):288-92. PubMed ID: 24880701
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunogenicity of a modified-live virus vaccine against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves.
    Xue W, Ellis J, Mattick D, Smith L, Brady R, Trigo E.
    Vaccine; 2010 May 14; 28(22):3784-92. PubMed ID: 20381643
    [Abstract] [Full Text] [Related]

  • 7. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
    Cortese VS, Grooms DL, Ellis J, Bolin SR, Ridpath JF, Brock KV.
    Am J Vet Res; 1998 Nov 14; 59(11):1409-13. PubMed ID: 9829398
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
    Ficken MD, Ellsworth MA, Tucker CM, Cortese VS.
    J Am Vet Med Assoc; 2006 May 15; 228(10):1559-64. PubMed ID: 16677126
    [Abstract] [Full Text] [Related]

  • 11. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A, Malacari DA, Perez Aguirreburualde MS, Bellido D, Nuñez MC, Dus Santos MJ, Escribano JM, Wigdorovitz A.
    Vaccine; 2015 Sep 22; 33(39):5163-71. PubMed ID: 26279338
    [Abstract] [Full Text] [Related]

  • 12. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves.
    Fulton RW, Briggs RE, Ridpath JF, Saliki JT, Confer AW, Payton ME, Duff GC, Step DL, Walker DA.
    Can J Vet Res; 2005 Jul 22; 69(3):161-9. PubMed ID: 16187545
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of protection from systemic infection and disease by use of a modified-live noncytopathic bovine viral diarrhea virus type 1 vaccine in experimentally infected calves.
    Kelling CL, Hunsaker BD, Steffen DJ, Topliff CL, Abdelmagid OY, Eskridge KM.
    Am J Vet Res; 2005 Oct 22; 66(10):1785-91. PubMed ID: 16273912
    [Abstract] [Full Text] [Related]

  • 18. Induction of antigen-specific T-cell subset activation to bovine respiratory disease viruses by a modified-live virus vaccine.
    Platt R, Burdett W, Roth JA.
    Am J Vet Res; 2006 Jul 22; 67(7):1179-84. PubMed ID: 16817740
    [Abstract] [Full Text] [Related]

  • 19. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine.
    Brock KV, McCarty K, Chase CC, Harland R.
    Vet Ther; 2006 Jul 22; 7(1):27-34. PubMed ID: 16598681
    [Abstract] [Full Text] [Related]

  • 20. Virus neutralising antibodies against 22 bovine viral diarrhoea virus isolates in vaccinated calves.
    Hamers C, Di Valentin E, Lecomte C, Lambot M, Joris E, Genicot B, Pastoret PP.
    Vet J; 2002 Jan 22; 163(1):61-7. PubMed ID: 11749137
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.